Skip to content

Trabeculectomy Versus Canaloplasty

Longterm Comparison Between Trabeculectomy and Canaloplasty in Open-angle Glaucoma

Status
Completed
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT01228799
Acronym
TVC
Enrollment
64
Registered
2010-10-27
Start date
2010-06-30
Completion date
2012-12-31
Last updated
2013-08-19

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Glaucoma, Canaloplasty, Trabeculectomy

Keywords

trabeculectomy,, canaloplasty,, glaucoma surgery, non-penetrating surgery

Brief summary

Study aims for comparison of trabeculectomy and canaloplasty, in order to find out if one operation is superior to the other. Both procedures are performed in patients with medically uncontrolled open-angle glaucoma. Canaloplasty is a recently newly introduced procedure, which showed encouraging results without antimetabolite usage intra- and postoperatively. Purpose of the study is to compare both surgeries concerning success rate, intraocular pressure, medication and complications. So far there is no comparison of the standard procedure trabeculectomy and the new approach, canaloplasty available.

Interventions

PROCEDUREtrabeculectomy

trabeculectomy with mitomycin C 0.2mg/ml

PROCEDURECanaloplasty

Canaloplasty with implant of suture

Sponsors

University Eye Hospital, Würzburg
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
TREATMENT
Masking
SINGLE (Subject)

Eligibility

Sex/Gender
ALL
Age
18 Years to No maximum
Healthy volunteers
No

Inclusion criteria

1. diagnosed primary or secondary open-angle glaucoma 2. IOP \> 16 mmHg (\<60 days prior surgery) 3. IOP \> 21 mmHg 4. no prior glaucoma surgery (once laser trabeculoplasty or cyclophotocoagulation) allowed

Exclusion criteria

1. angle closure glaucoma 2. congenital glaucoma 3. combined procedures (glaucoma and cataract)

Design outcomes

Primary

MeasureTime frameDescription
success rate (complete and qualified success)1 yearSuccess is defined 1. IOP \< 21 mmHg and at least 20% IOP reduction from baseline 2. IOP \< 18 mmHg

Secondary

MeasureTime frameDescription
IOP, medication, complications1 yearintraocular pressure reduction, medication postoperatively, complications intra- and postoperatively

Countries

Germany

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026